Markets › India › NSE › BLISSGVS

Bliss GVS Pharma Ltd

NSE:BLISSGVSHealthcare

₹627.05−3.83%At closeAt close · Mon 19 Oct · ≈ AED 24.23 · Market cap $736.97M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	42.2%	47.0%	46.9%	32.6%	48.9%	54.2%	—	—
Operating margin	14.6%	12.9%	13.5%	16.1%	35.1%	14.1%	14.1%	+0.0 pts
Net margin	12.0%	2.0%	9.5%	9.9%	10.4%	13.9%	20.4%	+6.5 pts
EBITDA margin	22.3%	10.3%	18.1%	19.4%	15.6%	25.4%	—	—
Return on equity	8.5%	1.8%	8.0%	7.8%	8.0%	10.8%	15.4%	+4.6 pts
Return on assets	6.4%	1.4%	6.1%	6.2%	6.5%	8.7%	12.7%	+4.1 pts
Return on capital employed	9.5%	10.9%	10.5%	11.7%	25.2%	10.4%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.0×	0.0×	−3.2%
Debt / assets	11.3%	9.9%	8.8%	8.2%	6.8%	1.5%	—	—
Interest coverage	15.1×	20.0×	9.7×	17.8×	35.0×	10.9×	—	—
Current ratio	3.8×	3.3×	3.6×	5.1×	4.8×	4.0×	4.0×	+0.0%
Quick ratio	3.3×	2.8×	3.1×	4.3×	4.1×	3.4×	—	—
Cash ratio	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.5×	0.7×	0.6×	0.6×	0.6×	0.6×	—	—
Inventory turnover	3.3×	3.2×	3.9×	4.4×	3.3×	2.8×	—	—
Receivables turnover	1.2×	1.8×	1.9×	1.9×	1.8×	1.8×	—	—
Dividend payout	8.1%	35.4%	7.7%	7.1%	6.5%	8.2%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.